Skip to main content
. 2022 Mar 14;88(7):e02430-21. doi: 10.1128/aem.02430-21

TABLE 4.

In vitro substrate range of purified pyruvate:alanine aminotransferasesa

Substrate class Substrate % conversion by PP_0596 % conversion by PP_2180 % conversion by PP_5182
Polyamines 1,3 diaminopropane 65 ± 0.9% 95 ± 0.7% 96 ± 3.5%
putrescine 2 ± 0.7% 109 ± 1.4% 112 ± 1.8%
cadaverine 9 ± 4.2% 97 ± 1.8% 103 ± 8.5%
1,6 diaminohexane 14 ± 1.5% 85 ± 4% 88 ± 0.6%
spermidine 101 ± 1.1% 105 ± 5.8% 112 ± 1.2%
ω-amino acids β-alanine 51 ± 0.5% NA NA
γ-aminobutyric acid 75 ± 2% 76 ± 1.5% 83 ± 4.2%
5-aminovaleric acid 70 ± 2.5% 71 ± 1.4% 73 ± 0.9%
6-aminocaproic acid 78 ± 1.9% 82 ± 0.8% 84 ± 1%
GABA isomers dl-2-aminobutyric 55 ± 1.3% 95 ± 1.2% 100 ± 5.6%
3-aminobutyric acid 87 ± 3.1% 12 ± 1.6% 16 ± 3.8%
dl-3-aminoisobutyric 70 ± 2.4% 6 ± 1.3% 12 ± 2.5%
Proteinogenic amino acids l-isoleucine NA NA 1 ± 0.5%
l-leucine NA 5 ± 0.7% NA
l-lysine 59 ± 49.4% 61 ± 3.8% 65 ± 4.9%
l-valine NA NA NA
a

Tested substrates were added in excess to pyruvate. Activity of the aminotransferases on the tested substrates was measured indirectly through the quantification of the co-product alanine. Percent conversion is relative to the expected measurement of alanine if the amine acceptor pyruvate was completely transformed. Error represents the standard deviation of three replicates. NA indicates that no activity was statistically detected above controls.